导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -12.69% | 3907/4766 |
| 近一周 | -5.00% | 5313/5457 |
| 近一月 | 0.92% | 285/5411 |
| 近一季 | 6.18% | 331/5229 |
| 近半年 | -18.67% | 4370/4923 |
| 近一年 | -11.96% | 3453/4393 |
| 近两年 | 26.99% | 2401/2948 |
| 近三年 | -2.11% | 1954/2248 |
| 成立以来 | -8.38% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.88% 2001/4961 |
-20.23% 4872/5312 |
- - |
- - |
| 2025 | 25.12% 1735/4813 |
-0.41% 2232/3635 |
7.97% 356/4076 |
13.30% 3009/4524 |
2.70% 875/4813 |
| 2024 | -9.70% 2334/3463 |
-5.52% 1921/2808 |
-5.07% 1634/3014 |
8.43% 2750/3129 |
-7.14% 2731/3463 |
| 2023 | -13.90% 1571/2656 |
0.74% 1708/2280 |
-12.05% 2172/2385 |
-3.36% 906/2515 |
0.56% 139/2655 |
| 2022 | -15.93% 440/2207 |
-5.58% 194/1919 |
3.71% 1104/2016 |
-11.44% 533/2113 |
-3.06% 1832/2208 |
| 2021 | -0.81% 760/1822 |
-1.18% 444/1255 |
-4.00% 1256/1330 |
-2.55% 578/1466 |
7.29% 185/1822 |
| 2020 | - - |
- - |
- - |
- - |
- - |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 富国中证农业主题ETF VS. 长安沪深300非周期A(740101) |